| Trial registration number
|
NCT04880174 |
Full text link
Last imported at : May 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04880174
|
First author
Last imported at : May 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Universitair Ziekenhuis Brussel - Sabine Allard
|
Contact
Last imported at : May 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
sabine.allard@uzbrussel.be
|
Registration date
Last imported at : May 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
2021-05-10
|
Recruitment status
Last imported at : Feb. 24, 2022, 6:30 p.m.
Source : ClinicalTrials.gov
|
Not recruiting
|
Study design
Last imported at : May 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
nonRCT
|
Allocation
Last imported at : May 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Non-randomized
|
Design
Last imported at : May 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Single group assignment
|
Masking
Last imported at : May 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Open label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : May 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Prevention
|
Inclusion criteria
Last imported at : May 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
- any adult employee of the uz brussel at t1 who has been vaccinated at the uz brussel
with mrna covid-19 vaccine (comirnaty®) between the 19th of january and the 5th of
february 2021 after participating to phase 4 of the covemuz study (with a maximum of 5
days difference between blood drawel and vaccination) and has provided a signed
informed consent.
|
Exclusion criteria
Last imported at : May 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
- uz brussel employees not active during the inclusion period (t1).
|
Number of arms
Last imported at : May 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
1
|
Funding
Last imported at : May 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Universitair Ziekenhuis Brussel
|
Inclusion age min
Last imported at : May 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : May 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : May 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Belgium
|
Type of patients
Last imported at : May 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Healthy volunteers
|
Severity scale
Last imported at : May 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
N/A
|
Total sample size
Last imported at : Feb. 24, 2022, 6:30 p.m.
Source : ClinicalTrials.gov
|
500
|
primary outcome
Last imported at : May 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Seroconversion;seroprevalence
|
Notes
Last imported at : May 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Arms
Last imported at : May 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "2", "treatment_id": 222, "treatment_name": "Bnt162b2", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}]
|